patient view
This page is a research summary built from public sources (FDA, NIH, clinical trial registries). It is not medical advice.Always talk to your doctor about treatment decisions. Drug information here may be incomplete or out of date — verify with your prescriber and the manufacturer's package insert.
drug · antibody
relatlimab
Phase 2updated 2mo agoby Bristol-Myers Squibb Co🔗 ChEMBL
Phase 2community read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with an approval for melanoma and 13 investigational indications.
indications
indications
NSCLCColorectal CancerDLBCL
targets
Lymphocyte activation gene 3 protein
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that